Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens

Younossi ZM, Stepanova M, Nader F, Jacobson IM, Gane EJ, Nelson DR, et al. Patient-reported outcomes in chronic hepatitis C patients with cirrhosis treated with sofosbuvir-containing regimens. Hepatology. 2014;59(6):2161-2169.

Publication Type:

Journal Article

Authors:

Z M Younossi; Stepanova, M.; Nader, F.; Ira M. Jacobson; E J Gane; David R. Nelson; E J Lawitz; Hunt, S.L.

Source:

Hepatology, Volume 59, Issue 6, p.2161-2169 (2014)

Keywords:

Adult, analogs & derivatives, Antiviral Agents, Anxiety, Chronic Disease, Clinical Trials,Phase III as Topic, complications, Depression, Disease, drug therapy, Drug Therapy,Combination, Fatigue, Female, HCV, Health, hepatitis, Hepatitis C, hepatitis C virus, Humans, interferon, Interferon-alpha, Life, Liver, Liver Cirrhosis, Liver Diseases, Male, Medicine, Middle Aged, Patients, peginterferon, pegylated, pegylated interferon, Polyethylene Glycols, Proteins, Quality of Life, Questionnaires, Recombinant Proteins, Research, Retrospective Studies, Ribavirin, sofosbuvir, therapeutic use, treatment, Treatment Outcome, Uridine, Uridine Monophosphate, Viral Load, Work

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/24710669

Export Citation:

RIS Format

Top